Class Action Lawsuit

FDA Reclassifies Vaginal Mesh as a High-Risk Device

The US Food and Drug Administration (FDA) today reclassified surgical mesh for trans-vaginal repair of pelvic organ prolapse (POP) from a moderate-risk device (class ll) to a high-risk one (class lll) and gave manufacturers 30 months to prove that their products are safe and effective, the agency announced. First proposed in April 2014, the regulations top

Delaware court reduces recent $100 million verdict against Boston Scientific

A Delaware court has reduced a recent 100 million (25 million compensatory damages and 75 million punitive damages) verdict against Boston Scientific relating to its class action lawsuit with their trans-vaginal mesh product to 10 million (2.5 million in compensatory damages and 7.5 in punitive damages). In doing so the court maintained the ration between



Takeda, Lilly Lose Bid to Overturn $9 Billion Actos Award – Judge Will Not Overturn Actos Verdict, Takeda Still Owes $9 Billion Takeda Pharmaceutical Co. and Eli Lilly& Co. lost a bid to have a judge throw out a combined $9 billion punitive-damage award over claims the drugmakers hid the cancer risks of their Actos

Mesh Update: J&J Must Pay Damages Mesh Incontinence Implant Verdict

Johnson & Johnson (JNJ) was ordered by a Texas jury to pay $1.2 million to a woman who alleged one of the company’s lines of vaginal-mesh implants to treat incontinence was defectively designed, in the first verdict against the company over those devices. Jurors in state court in Dallas concluded the design of the TVT-O